rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mohammad Hirmand

Director

Company insider

Files Form 4 as: Director, Whitehawk Therapeutics; EVP and Chief Medical Officer, Turning Point Therapeutics; Interim Chief Medical Officer, Medivation.

Every Form 4 they filed

In numbers

Trades disclosed
49
Buys
0
Sells
6
Bought
$0
Sold
$1.4M
Companies
3
Companies where not an officer
1
First trade
29 Sep 2015
Last trade
12 Jun 2026
Last filed
15 Jun 2026

Companies traded

Where they are an officer
Turning Point TherapeuticsOfficer · last 17 Aug 20220 buys · 3 sells
MedivationOfficer · last 28 Sep 20160 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
WHWK Whitehawk TherapeuticsDirector · Biotechnology · last 12 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Jun 2026filed 15 Jun 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—38,040 at $0.00filing
12 Jun 2026filed 15 Jun 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—38,040 at $0.00filing
12 Jun 2025filed 16 Jun 2025WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—40,006 at $0.00filing
12 Jun 2024filed 14 Jun 2024WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—45,832 at $0.00filing
27 Mar 2023filed 29 Mar 2023WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—59,206 at $0.00filing
17 Aug 2022filed 17 Aug 2022Turning Point Therapeuticsoption or derivativeSEC FORM 4 Code D—169,192filing
17 Aug 2022filed 17 Aug 2022Turning Point Therapeuticsoption or derivativeSEC FORM 4 Code D—29,175filing
17 Aug 2022filed 17 Aug 2022Turning Point Therapeuticsoption or derivativeSEC FORM 4 Code D—68,367filing
17 Aug 2022filed 17 Aug 2022Turning Point TherapeuticsSEC FORM 4 Code D$3.1M41,284 at $76.00filing
9 Feb 2022filed 11 Feb 2022Turning Point Therapeuticsoption or derivativeSEC FORM 4 Code A—68,367 at $0.00filing
9 Feb 2022filed 11 Feb 2022Turning Point TherapeuticsSEC FORM 4 Sold$24K669 at $36.30filing
9 Feb 2022filed 11 Feb 2022Turning Point TherapeuticsSEC FORM 4 Code A—18,983 at $0.00filing
9 Feb 2022filed 11 Feb 2022Turning Point TherapeuticsSEC FORM 4 Code A—15,000 at $0.00filing
8 Feb 2021filed 10 Feb 2021Turning Point TherapeuticsSEC FORM 4 Code A—6,483 at $0.00filing
8 Feb 2021filed 10 Feb 2021Turning Point Therapeuticsoption or derivativeSEC FORM 4 Code A—29,175 at $0.00filing
5 Jan 2021filed 5 Jan 2021Turning Point TherapeuticsSEC FORM 4 Code M$69K1,253 at $54.73filing
5 Jan 2021filed 5 Jan 2021Turning Point TherapeuticsSEC FORM 4 Sold$150K1,253 at $120.00filing
5 Jan 2021filed 5 Jan 2021Turning Point Therapeuticsoption or derivativeSEC FORM 4 Code M—1,253 at $0.00filing
4 Jan 2021filed 5 Jan 2021Turning Point TherapeuticsSEC FORM 4 Code M$479K8,747 at $54.73filing
4 Jan 2021filed 5 Jan 2021Turning Point TherapeuticsSEC FORM 4 Sold$37K300 at $122.44filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed6

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.